Joshua F. Patterson
CIK 1805702 · See Remarks · last filed 2026-04-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
13
Lifetime Open-Market Net
-$13.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CGON | See Remarks | — | $59.56 | — | $0 | 4 | 2026-04-16 |
| Gamida Cell Ltd. (GMDA) Delisted | GENERAL COUNSEL | 855,461 | $0.03 | $28.0K | $0 | 3 | 2024-02-02 |
| AKCEA THERAPEUTICS, INC. (AKCA) Delisted | General Counsel | 0 | — | — | -$13.0K | 6 | 2020-10-13 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-15 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Grant (A) | +12,500 | $0 | EDGAR |
| 2020-03-25 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Sell (S) | −335 | -$3.9K | EDGAR |
| 2020-03-23 | AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Grant (A) | +3,780 | $0 | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.